In its first few years, Medicare’s Part D prescription drug program helped seniors pay for their medications, but that trend appears to be reversing, researchers found. Meanwhile, drugmakers fight over the rules for naming cheaper versions of biologic drugs.

View the original here:
Seniors are less able to afford prescriptions, study finds

Scroll to Top